Cytoreductive nephrectomy for synchronous metastatic renal cell carcinoma. Is there enough evidence?

Cytoreductive nephrectomy for synchronous metastatic renal cell carcinoma. Is there enough evidence?

Objective: To assess the role of Cytoreductive Nephrectomy for synchronous metastatic Renal Cell Carcinoma patients in the Systemic Therapy era and beyond regarding the Overall Survival, the optimal sequence between Systemic Therapy and Cytoreductive Nephrectomy and prognostic factors. Methods: Th...

Full description

Bibliographic Details
Main Authors:	Stamatios Katsimperis, Lazaros Tzelves, Themistoklis Bellos, Konstantinos Pikramenos, Ioannis Manolitsis, Ioannis Tsikopoulos, Iraklis Mitsogiannis
Format:	Article
Language:	English
Published:	PAGEPress Publications 2022-12-01
Series:	Archivio Italiano di Urologia e Andrologia
Subjects:	cytoreductive nephrectomy metastatic renal cell carcinoma systematic therapy Immune check point inhibitors
Online Access:	https://www.pagepressjournals.org/index.php/aiua/article/view/10838

Similar Items

New Paradigms for Cytoreductive Nephrectomy
by: Benjamin J. Lichtbroun, et al.
Published: (2022-05-01)

Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy
by: Yan Song, et al.
Published: (2016-01-01)

Is Cytoreductive Nephrectomy Still a Standard of Care in Metastatic Renal Cell Carcinoma?
by: Alex Renner, et al.
Published: (2019-03-01)

Cytoreductive nephrectomy for metastatic renal cell carcinoma
by: Rajendra B Nerli
Published: (2013-01-01)

The role of active surveillance and cytoreductive nephrectomy in metastatic renal cell carcinoma
by: Amanda Nizam, et al.
Published: (2020-01-01)

Cytoreductive Nephrectomy and Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives
by: Luigi Napolitano, et al.
Published: (2023-04-01)

Cytoreductive Nephrectomy Following Immunotherapy-Base Treatment in Metastatic Renal Cell Carcinoma: A Case Series and Review of Current Literature
by: Scott J. Dawsey, et al.
Published: (2021-05-01)

Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial
by: Laura Iisager, et al.
Published: (2024-02-01)

The Evolving Landscape of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma
by: Hana Studentova, et al.
Published: (2023-07-01)

Diagnosis and management of intradiverticular bladder tumours: A pooled analysis of 498 cases
by: Stamatios Katsimperis, et al.
Published: (2022-12-01)

Cytoreductive Nephrectomy and Overall Survival of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy—Data from the National Renis Registry
by: Alexandr Poprach, et al.
Published: (2020-10-01)

The impact of cytoreductive nephrectomy on survival outcomes in patients with metastatic renal cell carcinoma receiving immunotherapy: An evidence-based analysis of comparative outcomes
by: Kun-peng Li, et al.
Published: (2023-03-01)

The role of cytoreductive nephrectomy in renal cell carcinoma patients with liver metastasis
by: Boda Guo, et al.
Published: (2021-04-01)

Do Metastatic Kidney Cancer Patients Benefit From Cytoreductive Nephrectomy? A Real-World Retrospective Study From the SEER Database
by: Cheng Li, et al.
Published: (2021-08-01)

Establishment and validation of a nomogram to select patients with metastatic sarcomatoid renal cell carcinoma suitable for cytoreductive radical nephrectomy
by: Yulin Zhou, et al.
Published: (2023-10-01)

Long-term outcomes after cytoreductive nephrectomy and thrombectomy of patients with metastatic renal cell carcinoma with venous tumor thrombus: a retrospective study from a large Chinese center
by: Kewei Chen, et al.
Published: (2023-06-01)

Indications and Outcomes for Deferred Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Combination Therapy: Can Systemic Therapy be Withdrawn in Patients with No Evidence of Disease?
by: Elisabeth E. Fransen van de Putte, et al.
Published: (2023-09-01)

Effect of Inferior Vena Cava Tumor Thrombus on Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Cytoreductive Nephrectomy
by: Benedikt Hoeh, et al.
Published: (2022-10-01)

A case of metastatic renal cell carcinoma successfully treated with deferred cytoreductive nephrectomy following lenvatinib plus pembrolizumab combination therapy
by: Hiroaki Sato, et al.
Published: (2023-05-01)

A rapid progression of new metastatic lesion after cytoreductive nephrectomy: A case report
by: Steven Steven, et al.
Published: (2021-11-01)

Cytoreductive Nephrectomy in Select Primary Metastatic Renal Cell Carcinoma Patients: A Comprehensive Nationwide Outcome Analysis
by: Nessn Azawi, et al.
Published: (2024-03-01)

Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals
by: Daniel D. Shapiro, et al.
Published: (2023-04-01)

Selection of Optimal Candidates for Cytoreductive Nephrectomy in Patients with Metastatic Clear Cell Renal Cell Carcinoma: A Predictive Model Based on SEER Database
by: Yishan Zhang, et al.
Published: (2022-01-01)

The Effect of Cytoreductive Partial Nephrectomy in Elderly Patients with Metastatic Renal Cell Carcinoma
by: Chen J, et al.
Published: (2020-03-01)

The Role of Cytoreductive Nephrectomy in Renal Cell Carcinoma with Sarcomatoid Histology: A Case Series and Review of the Literature
by: Hana Studentova, et al.
Published: (2022-08-01)

A Case of Metastatic Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome-Associated Renal Cell Carcinoma Treated with a Sequence of Axitinib and Nivolumab Following Cytoreductive Nephrectomy
by: Ichiro Yonese, et al.
Published: (2020-07-01)

Metastatic renal cell carcinoma patients of T4 stage who are in status of N1 stage or older than 76 years cannot benefit from cytoreductive nephrectomy
by: Zhao Zhang, et al.
Published: (2020-09-01)

Machine learning to improve prognosis prediction of metastatic clear-cell renal cell carcinoma treated with cytoreductive nephrectomy and systemic therapy
by: Wenjie Yang, et al.
Published: (2023-05-01)

Complete remission of renal cell carcinoma with lung carcinomatous lymphangiosis after primary therapy with immune checkpoint inhibitors followed by partial nephrectomy for surgical consolidation
by: Takanari Kambe, et al.
Published: (2022-05-01)

Deliberation on Deferred Cytoreductive Nephrectomy and Postoperative Treatment for Advanced Renal Cell Carcinoma: A Case Report
by: Takuya Nakagawa, et al.
Published: (2022-11-01)

Transdiaphragmatic nephrectomy with synchronous pulmonary and anterior thoracic wall mass metastasectomy in a young male with metastatic renal cell carcinoma; a single-incision approach
by: Lazaros Lazarou, et al.
Published: (2021-01-01)

Health-Related Quality of Life following Cytoreductive Radical Prostatectomy in Patients with De-Novo Oligometastatic Prostate Cancer
by: Michael Chaloupka, et al.
Published: (2021-11-01)

Quaternary and beyond cytoreduction: An updated and expanded analysis
by: Beryl L. Manning-Geist, et al.
Published: (2021-08-01)

Long-Term Survival Outcomes of Cytoreductive Nephrectomy Combined with Targeted Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Individual Patient Data Meta-Analysis
by: Stepan M. Esagian, et al.
Published: (2021-02-01)

Nephrectomy improves the survival of metastatic renal cell cancer patients with moderate to good performance status—results from a Finnish nation-wide population-based study from 2005 to 2010
by: Lauri Laru, et al.
Published: (2021-06-01)

An Updated Systematic and Comprehensive Review of Cytoreductive Prostatectomy for Metastatic Prostate Cancer
by: Takafumi Yanagisawa, et al.
Published: (2023-02-01)

Severe Dyspnea due to Pulmonary Metastasis of Renal Cell Carcinoma: Is Cytoreductive Surgery of Value
by: Mohammad Kazem Moslemi, et al.
Published: (2010-09-01)

Pathological Complete Response of Metastatic Clear Cell Renal Carcinoma with Pembrolizumab and Axitinib: A Case Report and Review of Literature
by: Amir F. Beirat, et al.
Published: (2023-02-01)

Cytoreductive nephrectomy in the age of immunotherapy-based combination treatment
by: Sang Hun Song, et al.
Published: (2023-09-01)

Cytoreductive radiotherapy combined with abiraterone in metastatic castration-resistance prostate cancer: a single center experience
by: Yang Liu, et al.
Published: (2021-01-01)